NeuroPace, Inc. ( NPCE) - Key Metrics
NPCE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.81 | -$0.08 | $0.02 | $0.01 |
| 2025Q3 | $0.83 | -$0.11 | -$0.06 | -$0.06 |
| 2025Q2 | $0.72 | -$0.26 | -$0.06 | -$0.07 |
| 2025Q1 | $0.72 | -$0.21 | -$0.24 | -$0.24 |
NPCE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -46.28 |
| 2025Q3 | ? | -24.43 |
| 2025Q2 | ? | -10.58 |
| 2025Q1 | ? | -14.68 |
NPCE
Price: $15.64
52 week price:
Earnings Per Share: -0.65 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 24800
Market Capitalization: 541.4 million